First-In-Human Study of STX-721/PFL-721 in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring EGFR or HER2 Exon 20 Insertion Mutations
Conditions
Non-Small Cell Lung Cancer · NSCLC · EGFR/HER2 Exon 20 Insertion Mutation
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
City of Hope, Duarte, California, United States
City of Hope, Huntington Beach, California, United States
City of Hope, Irvine, California, United States
Levine Cancer Institute - Charlotte, Charlotte, North Carolina, United States
Thomas Jefferson University Research Facility, Philadelphia, Pennsylvania, United States
SCRI Oncology Partners - PPDS, Nashville, Tennessee, United States
University of Texas MD Anderson Cancer Center, Houston, Texas, United States
University of Utah - Huntsman Cancer Institute - PPDS, Salt Lake City, Utah, United States
NEXT Virginia, Fairfax, Virginia, United States
EDOG Institut de Cancerologie de l'Ouest - PPDS, Saint-Herblain, Loire-Atlantique, France
Institut Claudius Regaud - PPDS, Toulouse, France
Gustave Roussy, Villejuif, France
Charité - Universitätsmedizin Berlin (CBF) - Hindenburgdamm 30, Berlin, Germany
Universitätsklinikum Carl Gustav Carus an der TU Dresden, Dresden, Germany
Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis, Amsterdam, Netherlands
Chungbuk National University Hospital, Cheongju-si, South Korea
CHA Bundang Medical Center, CHA University, Seongnam-si, South Korea
Seoul National University Hospital, Seoul, South Korea
Hospital Regional Universitario de Malaga - Hospital General, Málaga, Malaga, Spain
Instituto de Investigacion Oncologica Vall dHebron (VHIO) - EPON, Barcelona, Spain
Hospital Universitario Ramon y Cajal, Madrid, Spain
Hospital Universitario Virgen del Rocio, Seville, Spain
National Taiwan University Hospital, Taipei, Taiwan
Taipei Veterans General Hospital, Taipei, Taiwan